Literature DB >> 7745446

N-acetylated alpha-linked acidic dipeptidase is expressed by non-myelinating Schwann cells in the peripheral nervous system.

U V Berger1, R E Carter, M McKee, J T Coyle.   

Abstract

N-acetylated alpha-linked acidic dipeptidase is a membrane-bound brain peptidase which cleaves the neuropeptide N-acetyl-aspartyl-glutamate to N-acetyl-aspartate and glutamate. In the present study, we have determined the localization of N-acetylated alpha-linked acidic dipeptidase in the peripheral nervous system. Using enzyme assays and immunoblotting, we demonstrate that sciatic nerve, phrenic nerve, cervical dorsal root ganglion and superior cervical ganglion contain N-acetylated alpha-linked acidic dipeptidase activity as well as an N-acetylated alpha-linked acidic dipeptidase-like protein. Furthermore, we show that N-acetylated alpha-linked acidic dipeptidase-like immunoreactivity is extensively co-localized in peripheral nerves with immunoreactivity for glial fibrillary acidic protein, a known marker for non-myelinating Schwann cells. Using electron microscopy, we demonstrate N-acetylated alpha-linked acidic dipeptidase-like immunoreactivity in cell membranes of non-myelinating Schwann cells in the superior cervical ganglion. These results show that N-acetylated alpha-linked acidic dipeptidase is expressed in the peripheral nervous system by non-myelinating Schwann cells. This cellular localization suggests that N-acetylated alpha-linked acidic dipeptidase may be involved in the signalling between axons and Schwann cells, for example during development or regeneration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745446     DOI: 10.1007/BF01181553

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  14 in total

Review 1.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

Review 2.  Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer.

Authors:  C Bařinka; C Rojas; B Slusher; M Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 3.  Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.

Authors:  James J Vornov; Diane Peters; Mike Nedelcovych; Kristen Hollinger; Rana Rais; Barbara S Slusher
Journal:  Neurochem Res       Date:  2019-11-20       Impact factor: 3.996

4.  Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II.

Authors:  R Luthi-Carter; U V Berger; A K Barczak; M Enna; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

5.  Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.

Authors:  Valentina A Carozzi; Alessia Chiorazzi; Annalisa Canta; Rena G Lapidus; Barbara S Slusher; Krystyna M Wozniak; Guido Cavaletti
Journal:  Neurotox Res       Date:  2009-09-15       Impact factor: 3.911

6.  Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.

Authors:  R E Carter; A R Feldman; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

7.  Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.

Authors:  Cyril Barinka; Pavel Sácha; Jan Sklenár; Petr Man; Karel Bezouska; Barbara S Slusher; Jan Konvalinka
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

8.  The calcium-binding site of human glutamate carboxypeptidase II is critical for dimerization, thermal stability, and enzymatic activity.

Authors:  Jakub Ptacek; Jana Nedvedova; Michal Navratil; Barbora Havlinova; Jan Konvalinka; Cyril Barinka
Journal:  Protein Sci       Date:  2018-09       Impact factor: 6.725

9.  Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction.

Authors:  Kathryn K Walder; Steve B Ryan; Tomasz Bzdega; Rafal T Olszewski; Joseph H Neale; Clark A Lindgren
Journal:  Eur J Neurosci       Date:  2012-11-08       Impact factor: 3.386

10.  Glutamate carboxypeptidase activity in human skin biopsies as a pharmacodynamic marker for clinical studies.

Authors:  Camilo Rojas; Marigo Stathis; Michael Polydefkis; Michelle A Rudek; Ming Zhao; Gigi J Ebenezer; Barbara S Slusher
Journal:  J Transl Med       Date:  2011-03-09       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.